Robot buddies let kids with cancer attend class from hospital bed
NCT ID NCT07398677
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether telepresence robots can help children aged 5-17 with cancer attend school remotely when they can't be there in person. The robots let kids see, hear, and talk in class from their hospital or home. Researchers will track school attendance, social well-being, and academic progress over eight months in 128 children across three Danish hospitals.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- telepresence robot (AV1 or BEAM) plus school navigation support
- What this could lead to
- If it works, this could help children with cancer stay connected to school and peers during treatment, reducing long-term academic and social setbacks.
- What could go wrong
- This is a relatively small, early-stage study (128 participants) testing a device and support program, not a drug. Results may not apply to all children or settings, and the robot may not fully replace in-person attendance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACADEMIC LEVEL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aalborg Universitetshospital
RECRUITINGAalborg, Denmark
-
Aarhus Universitetshospital
RECRUITINGAarhus, Denmark
-
Rigshospitalet
RECRUITINGCopenhagen, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can trained immune cells stop blood cancer relapse?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare